Literature DB >> 27660064

Clinical significance of coagulase-negative staphylococci other than S. epidermidis blood stream isolates at a tertiary care hospital.

Florian Hitzenbichler1,2, Michaela Simon3, Bernd Salzberger4, Frank Hanses4,5.   

Abstract

PURPOSE: We retrospectively evaluated blood culture (BC) isolates of coagulase-negative staphylococci other than Staphylococcus epidermidis (NonSe-CoNS) for clinical relevance at a tertiary care hospital in Germany from January 2011 to September 2015.
METHODS: Clinical data were correlated to microbiological results based on medical records. Infection was considered likely if (1) no other infection and (2) two or more isolates of the same species were present and (3) symptoms ameliorated after therapy. Infection was considered possible if a foreign body was present and (1) and (3) were fulfilled. All the other cases were considered contaminations.
RESULTS: 313 patients with blood cultures positive for NonSe-CoNS were identified. 61 patients were excluded, either because of missing data or multiple pathogens in the same blood culture. Of the remaining 252 patients, 58 (23 %) were classified as possible (n = 32) or likely (n = 26) infections. S. haemolyticus was the most frequent isolate (infection: n = 28), followed by S. hominis (n = 13), S. capitis (n = 12), and S. lugdunensis (n = 3). One patient died from NonSe-CoNS infection. The source of infection in the majority of patients was foreign bodies (n = 43), and endocarditis was present in six cases. Staphylococci always considered contaminations were: S. auricularis, S. caprae, S. schleiferi, S. pettenkoferi, S. saccharolyticus, and S. simulans. The growth of NonSe-CoNS in the anaerobic BC bottle only and a time to positivity >36 h were associated with contaminations.
CONCLUSIONS: One out of four NonSe-CoNS isolates was clinically relevant in our cohort, where S. haemolyticus, S. capitis, S. hominis, and S. lugdunensis contributed to 96.6 % of all relevant infections.

Entities:  

Keywords:  Bacteremia; Blood culture; Coagulase-negative Staphylococci; Contamination; S. haemolyticus; S. lugdunensis

Mesh:

Substances:

Year:  2016        PMID: 27660064     DOI: 10.1007/s15010-016-0945-4

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  30 in total

1.  Determining the significance of coagulase-negative staphylococci isolated from blood cultures at a community hospital: a role for species and strain identification.

Authors:  S D Kim; L C McDonald; W R Jarvis; S K McAllister; R Jerris; L A Carson; J M Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2000-03       Impact factor: 3.254

2.  Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999.

Authors:  D J Diekema; M A Pfaller; F J Schmitz; J Smayevsky; J Bell; R N Jones; M Beach
Journal:  Clin Infect Dis       Date:  2001-05-15       Impact factor: 9.079

3.  Clinical significance of a single Staphylococcus lugdunensis-positive blood culture.

Authors:  Hind J Fadel; Robin Patel; Emily A Vetter; Larry M Baddour
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

4.  When is coagulase-negative Staphylococcus bacteraemia clinically significant?

Authors:  Elisa García-Vázquez; Ana Fernández-Rufete; Alicia Hernández-Torres; Manuel Canteras; Joaquín Ruiz; Joaquín Gómez
Journal:  Scand J Infect Dis       Date:  2013-07-01

5.  Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases.

Authors:  Marco Falcone; Floriana Campanile; Maddalena Giannella; Sonia Borbone; Stefania Stefani; Mario Venditti
Journal:  Diagn Microbiol Infect Dis       Date:  2006-12-01       Impact factor: 2.803

6.  Clinical prognostic factors for time to positivity in cancer patients with bloodstream infections.

Authors:  Qing Zhang; Ding Li; Changsen Bai; Wenfang Zhang; Shan Zheng; Peng Zhang; Sihe Zhang
Journal:  Infection       Date:  2016-03-18       Impact factor: 3.553

7.  Staphylococcus lugdunensis: a rare but destructive cause of coagulase-negative staphylococcus infective endocarditis.

Authors:  Marwa A Sabe; Nabin K Shrestha; Steven Gordon; Venu Menon
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2014-02-12

8.  Role of coagulase-negative staphylococci in human disease.

Authors:  A Piette; G Verschraegen
Journal:  Vet Microbiol       Date:  2008-09-11       Impact factor: 3.293

9.  Clinical experience with Staphylococcus lugdunensis bacteremia: a retrospective analysis.

Authors:  John R Ebright; Neelima Penugonda; William Brown
Journal:  Diagn Microbiol Infect Dis       Date:  2004-01       Impact factor: 2.803

Review 10.  Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature.

Authors:  A S Zinkernagel; M S Zinkernagel; M V Elzi; M Genoni; J Gubler; R Zbinden; N J Mueller
Journal:  Infection       Date:  2008-07-21       Impact factor: 3.553

View more
  15 in total

1.  Coagulase-negative staphylococci in outpatient routines: the implications of switching from CLSI to BrCAST/EUCAST guidelines.

Authors:  Vinícius Pietta Perez; Jéssica Karoliny Baptista Porto Carvalho; Marianne Schrader de Oliveira; Adriana Medianeira Rossato; Caroline Dani; Gertrudes Corção; Pedro Alves d'Azevedo
Journal:  Braz J Microbiol       Date:  2020-04-23       Impact factor: 2.476

2.  Comparison of the etiological relevance of Staphylococcus haemolyticus and Staphylococcus hominis.

Authors:  Hagen Frickmann; Andreas Hahn; Romy Skusa; Nils Mund; Vivian Viehweger; Thomas Köller; Kerstin Köller; Norbert Georg Schwarz; Karsten Becker; Philipp Warnke; Andreas Podbielski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-19       Impact factor: 3.267

3.  Phenol-Soluble Modulin Toxins of Staphylococcus haemolyticus.

Authors:  Fei Da; Hwang-Soo Joo; Gordon Y C Cheung; Amer E Villaruz; Holger Rohde; Xiaoxing Luo; Michael Otto
Journal:  Front Cell Infect Microbiol       Date:  2017-05-24       Impact factor: 5.293

4.  Hyperosmotic Infusion and Oxidized Surfaces Are Essential for Biofilm Formation of Staphylococcus capitis From the Neonatal Intensive Care Unit.

Authors:  Yue Qu; Yali Li; David R Cameron; Christopher D Easton; Xuebo Zhu; Minli Zhu; Mario Salwiczek; Benjamin W Muir; Helmut Thissen; Andrew Daley; John S Forsythe; Anton Y Peleg; Trevor Lithgow
Journal:  Front Microbiol       Date:  2020-05-13       Impact factor: 5.640

5.  Staphylococcus haemolyticus epididymo-orchitis and bacteraemia: a case report.

Authors:  Christina Pindar; Roberto A Viau
Journal:  JMM Case Rep       Date:  2018-07-05

6.  Multidrug-resistant Staphylococcus pettenkoferi isolated from cat in India.

Authors:  Tapan Kumar Dutta; Satyaki Chakraborty; Malay Das; Rajkumari Mandakini; Parimal Roychoudhury; Santanu Ghorai; Suvendu Kumar Behera
Journal:  Vet World       Date:  2018-10-05

7.  Periprosthetic Joint Infections as a Consequence of Bacteremia.

Authors:  Meeri Honkanen; Esa Jämsen; Matti Karppelin; Reetta Huttunen; Antti Eskelinen; Jaana Syrjänen
Journal:  Open Forum Infect Dis       Date:  2019-05-07       Impact factor: 3.835

8.  Two Blood Cultures With Age-Appropriate Volume Enhance Suspected Sepsis Decision-Making.

Authors:  Paul Tran; Elaine Dowell; Stacey Hamilton; Susan A Dolan; Kevin Messacar; Samuel R Dominguez; James Todd
Journal:  Open Forum Infect Dis       Date:  2020-01-27       Impact factor: 3.835

9.  Staphylococcus saccharolyticus infection: case series with a PRISMA-compliant systemic review.

Authors:  Ping Wang; Yali Liu; Yingchun Xu; Zuojun Xu
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

10.  Staphylococcal species less frequently isolated from human clinical specimens - are they a threat for hospital patients?

Authors:  Magdalena Szemraj; Magdalena Grazul; Ewa Balcerczak; Eligia M Szewczyk
Journal:  BMC Infect Dis       Date:  2020-02-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.